Coagulation and fibrinolysis in thyroid dysfunction

go back to reference A. Squizzato, V.E. Gerdes, D.P. Brandjes, H.R. Büller, J. Stam, Thyroid diseases and cerebrovascular disease. Stroke 36, 2302–2310 (2005)CrossRefPubMed A. Squizzato, V.E. Gerdes, D.P. Brandjes, H.R. Büller, J. Stam, Thyroid diseases and cerebrovascular disease. Stroke 36, 2302–2310 (2005)CrossRefPubMed

go back to reference A. Squizzato, E. Romualdi, H.R. Büller, V.E. Gerdes, Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J. Clin. Endocrinol. Metab. 92, 2415–2420 (2007)CrossRefPubMed A. Squizzato, E. Romualdi, H.R. Büller, V.E. Gerdes, Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J. Clin. Endocrinol. Metab. 92, 2415–2420 (2007)CrossRefPubMed

go back to reference L.C. Hofbauer, A.E. Heufelder, Coagulation disorders in thyroid diseases. Eur. J. Endocrinol. 136, 1–7 (1997)CrossRefPubMed L.C. Hofbauer, A.E. Heufelder, Coagulation disorders in thyroid diseases. Eur. J. Endocrinol. 136, 1–7 (1997)CrossRefPubMed

go back to reference M. Franchini, Hemostatic changes in thyroid diseases. Hematology 11, 203–208 (2006)CrossRefPubMed M. Franchini, Hemostatic changes in thyroid diseases. Hematology 11, 203–208 (2006)CrossRefPubMed

go back to reference C. Erem, H. Kavgacı, H.Ö. Ersoz, A. Hacıhasanoğlu, K. Ukinç, S.S. Kartı, O. Değer, M. Telatar, Blood coagulation and fibrinolytic activity in hypothyroidism. Int. J. Clin. Pract. 57, 78–81 (2003)PubMed C. Erem, H. Kavgacı, H.Ö. Ersoz, A. Hacıhasanoğlu, K. Ukinç, S.S. Kartı, O. Değer, M. Telatar, Blood coagulation and fibrinolytic activity in hypothyroidism. Int. J. Clin. Pract. 57, 78–81 (2003)PubMed

go back to reference L. Porter, S.J. Mandel, The blood in thyrotoxicosis, in Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text, 8th edn., ed. by L.E. Braverman, R.D. Utiger (Lippincott Williams & Wilkins, Philadelphia, 2000), pp. 627–631 L. Porter, S.J. Mandel, The blood in thyrotoxicosis, in Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text, 8th edn., ed. by L.E. Braverman, R.D. Utiger (Lippincott Williams & Wilkins, Philadelphia, 2000), pp. 627–631

go back to reference Y. Kurata, Y. Nishioeda, T. Tsubakio, Thrombocytopenia in Graves’ disease: effect of T3 on platelet kinetics. Acta Haematol 63, 185–190 (1980)CrossRefPubMed Y. Kurata, Y. Nishioeda, T. Tsubakio, Thrombocytopenia in Graves’ disease: effect of T₃ on platelet kinetics. Acta Haematol 63, 185–190 (1980)CrossRefPubMed

go back to reference S. Panzer, A. Haubenstock, E. Minar, Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. J. Clin. Endocrinol. Metab. 70, 491–496 (1990)CrossRefPubMed S. Panzer, A. Haubenstock, E. Minar, Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. J. Clin. Endocrinol. Metab. 70, 491–496 (1990)CrossRefPubMed

go back to reference K. Hymes, M. Blum, H. Lackner, S. Karpatkin, Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves’ disease and Hashimoto’s thyroiditis. Ann. Intern. Med. 94, 27–30 (1981)PubMed K. Hymes, M. Blum, H. Lackner, S. Karpatkin, Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves’ disease and Hashimoto’s thyroiditis. Ann. Intern. Med. 94, 27–30 (1981)PubMed

go back to reference N. Bizzaro, Familial association of autoimmune thrombocytopenia and hyperthyroidism. Am. J. Hematol. 39, 294–298 (1992)CrossRefPubMed N. Bizzaro, Familial association of autoimmune thrombocytopenia and hyperthyroidism. Am. J. Hematol. 39, 294–298 (1992)CrossRefPubMed

go back to reference K. Yamaguchi, Y. Ookubo, H. Matsuda, K. Suzaki, H. Fukushima, H. Uzawa, Idiopathic thrombocytopenic purpura subsequent to Graves’ disease and insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 3, 233–237 (1987)CrossRefPubMed K. Yamaguchi, Y. Ookubo, H. Matsuda, K. Suzaki, H. Fukushima, H. Uzawa, Idiopathic thrombocytopenic purpura subsequent to Graves’ disease and insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 3, 233–237 (1987)CrossRefPubMed

go back to reference S.L. Ho, M. Shah, A.C. Williams, Idiopathic thrombocytopenic purpura and autoimmune thyroiditis in a patient with myasthenia gravis. Muscle Nerve 15, 966–967 (1992)PubMed S.L. Ho, M. Shah, A.C. Williams, Idiopathic thrombocytopenic purpura and autoimmune thyroiditis in a patient with myasthenia gravis. Muscle Nerve 15, 966–967 (1992)PubMed

go back to reference I. Cordiano, C. Betterle, C.A. Spadaccino, B. Soini, A. Girolami, F. Fabris, Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin. Exp. Immunol. 113, 373–378 (1998)CrossRefPubMed I. Cordiano, C. Betterle, C.A. Spadaccino, B. Soini, A. Girolami, F. Fabris, Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin. Exp. Immunol. 113, 373–378 (1998)CrossRefPubMed

go back to reference J.S. Marshall, A.S. Weisberger, R.P. Levy, Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism. Ann. Intern. Med. 67, 411–414 (1967) J.S. Marshall, A.S. Weisberger, R.P. Levy, Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism. Ann. Intern. Med. 67, 411–414 (1967)

go back to reference A. Adrouny, R.M. Sandler, R. Carmel, Variable presentation of thrombocytopenia in Graves’ disease. Arch. Intern. Med. 142, 1460–1464 (1982)CrossRefPubMed A. Adrouny, R.M. Sandler, R. Carmel, Variable presentation of thrombocytopenia in Graves’ disease. Arch. Intern. Med. 142, 1460–1464 (1982)CrossRefPubMed

go back to reference F. Marongiu, M. Conti, M.L. Murtas, G.G. Sorano, G. Mameli, G. Salis, A. Mathieu, E. Martino, Anticardiolipin antibodies in Graves’ disease: relationship with thrombin activity in vivo. Thromb. Res. 64, 745–749 (1991)CrossRefPubMed F. Marongiu, M. Conti, M.L. Murtas, G.G. Sorano, G. Mameli, G. Salis, A. Mathieu, E. Martino, Anticardiolipin antibodies in Graves’ disease: relationship with thrombin activity in vivo. Thromb. Res. 64, 745–749 (1991)CrossRefPubMed

go back to reference L.C. Hofbauer, C. Spitzweg, A.E. Heufelder, Graves’ disease associated with the primary antiphospholipid syndrome. J. Rheumatol. 23, 1435–1437 (1996)PubMed L.C. Hofbauer, C. Spitzweg, A.E. Heufelder, Graves’ disease associated with the primary antiphospholipid syndrome. J. Rheumatol. 23, 1435–1437 (1996)PubMed

go back to reference P. Dagenais, M.B. Urowitz, D.D. Gladman, C.S. Norman, A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J. Rheumatol. 19, 1393–1396 (1992)PubMed P. Dagenais, M.B. Urowitz, D.D. Gladman, C.S. Norman, A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J. Rheumatol. 19, 1393–1396 (1992)PubMed

go back to reference C. Erem, H.Ö. Ersoz, S.S. Kartı, K. Ukinç, A. Hacıhasanoğlu, O. Değer, M. Telatar, Blood coagulation and fibrinolysis in patients with hyperthyroidism. J. Endocrinol. Invest. 25, 345–350 (2002)PubMed C. Erem, H.Ö. Ersoz, S.S. Kartı, K. Ukinç, A. Hacıhasanoğlu, O. Değer, M. Telatar, Blood coagulation and fibrinolysis in patients with hyperthyroidism. J. Endocrinol. Invest. 25, 345–350 (2002)PubMed

go back to reference J.S. Rogers, S.R. Shane, F.S. Jencks, Factor VIII activity and thyroid function. Ann. Intern. Med. 97, 713–716 (1982)PubMed J.S. Rogers, S.R. Shane, F.S. Jencks, Factor VIII activity and thyroid function. Ann. Intern. Med. 97, 713–716 (1982)PubMed

go back to reference F. Marongiu, M. Conti, M.L. Murtas, G. Mameli, G.G. Sorano, E. Martino, Activation of blood coagulation and fibrinolysis in Graves’ disease. Horm. Metab. Res. 23, 609–611 (1991)CrossRefPubMed F. Marongiu, M. Conti, M.L. Murtas, G. Mameli, G.G. Sorano, E. Martino, Activation of blood coagulation and fibrinolysis in Graves’ disease. Horm. Metab. Res. 23, 609–611 (1991)CrossRefPubMed

go back to reference F. Marongiu, M. Conti, G. Mameli, M.L. Murtas, S. Balzano, G. Sorano, A.M. Mamusa, E. Martino, Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J. Endocrinol. Invest. 11, 723–725 (1988)PubMed F. Marongiu, M. Conti, G. Mameli, M.L. Murtas, S. Balzano, G. Sorano, A.M. Mamusa, E. Martino, Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J. Endocrinol. Invest. 11, 723–725 (1988)PubMed

go back to reference M. Franchini, Hemostasis and thyroid diseases revisited. J. Endocrinol. Invest. 27, 886–892 (2004)PubMed M. Franchini, Hemostasis and thyroid diseases revisited. J. Endocrinol. Invest. 27, 886–892 (2004)PubMed

go back to reference J. Burggraaf, S. Lalezari, J.J. Emeis, U.M. Vischer, P.H. de Meyer, H. Pijl, A.F. Cohen, Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 11, 153–160 (2001)CrossRefPubMed J. Burggraaf, S. Lalezari, J.J. Emeis, U.M. Vischer, P.H. de Meyer, H. Pijl, A.F. Cohen, Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 11, 153–160 (2001)CrossRefPubMed

go back to reference M. Soma, Y. Maeda, R. Matsuura, I. Sasaki, S. Kasakura, Y. Saeki, K. Ikekubo, T. Ishihara, H. Kurahachi, S. Sasaki, T. Tagami, K. Nakao, Study of serum thrombomodulin (TM) levels in patients with hyper- or hypo-thyroidism. Rinsho Byori 45, 77–81 (1997)PubMed M. Soma, Y. Maeda, R. Matsuura, I. Sasaki, S. Kasakura, Y. Saeki, K. Ikekubo, T. Ishihara, H. Kurahachi, S. Sasaki, T. Tagami, K. Nakao, Study of serum thrombomodulin (TM) levels in patients with hyper- or hypo-thyroidism. Rinsho Byori 45, 77–81 (1997)PubMed

go back to reference L. Liu, X. Wang, Z. Lin, H. Wu, Elevated plasma levels of VWF:Ag in hyperthyroidism are mediated through beta-adrenergic receptors. Endocr. Res. 19, 123–133 (1993)CrossRefPubMed L. Liu, X. Wang, Z. Lin, H. Wu, Elevated plasma levels of VWF:Ag in hyperthyroidism are mediated through beta-adrenergic receptors. Endocr. Res. 19, 123–133 (1993)CrossRefPubMed

go back to reference Ö. Üçüncü, C. Erem, M. Yılmaz, H.O. Ersöz, M. Koçak, İ. Nuhoğlu, Hipertiroidili hastalarda hemostatik değişiklikler: artmış trombinle aktive edilebilen fibrinoliz inhibitörü (TAFI) ve azalmış doku faktör yolağı inhibitörü (TFPI). 3. Türkiye Tiroid Hastalıkları Kongresi, 17–20 Nisan 2008, Trabzon, Özet Kitabı, Sayfa 17, P04 (2008) Ö. Üçüncü, C. Erem, M. Yılmaz, H.O. Ersöz, M. Koçak, İ. Nuhoğlu, Hipertiroidili hastalarda hemostatik değişiklikler: artmış trombinle aktive edilebilen fibrinoliz inhibitörü (TAFI) ve azalmış doku faktör yolağı inhibitörü (TFPI). 3. Türkiye Tiroid Hastalıkları Kongresi, 17–20 Nisan 2008, Trabzon, Özet Kitabı, Sayfa 17, P04 (2008)

go back to reference Y. Morikawa, A. Morikawa, I. Makino, Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves’ disease: TM, a possible new marker of the peripheral activity of thyroid hormones. J. Clin. Endocrinol. Metab. 76, 609–614 (1993)CrossRefPubMed Y. Morikawa, A. Morikawa, I. Makino, Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves’ disease: TM, a possible new marker of the peripheral activity of thyroid hormones. J. Clin. Endocrinol. Metab. 76, 609–614 (1993)CrossRefPubMed

go back to reference M.A. Ozcan, A. Comlekci, F. Demirkan, F. Yuksel, I. Sari, T. Demir, G.H. Ozsan, G. Oruk, S. Yesil, B. Undar, Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thromb. Res. 110, 243–247 (2003)CrossRefPubMed M.A. Ozcan, A. Comlekci, F. Demirkan, F. Yuksel, I. Sari, T. Demir, G.H. Ozsan, G. Oruk, S. Yesil, B. Undar, Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thromb. Res. 110, 243–247 (2003)CrossRefPubMed

go back to reference B. Akinci, A. Comlekci, S. Yener, T. Demir, M.A. Ozcan, F. Bayraktar, S. Yesil, Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients. Endocr. J. 54, 593–599 (2007)CrossRefPubMed B. Akinci, A. Comlekci, S. Yener, T. Demir, M.A. Ozcan, F. Bayraktar, S. Yesil, Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients. Endocr. J. 54, 593–599 (2007)CrossRefPubMed

go back to reference F. Marongiu, C. Cauli, S. Mariotti, Thyroid, hemostasis and thrombosis. J. Endocrinol. Invest. 27, 1065–1071 (2004)PubMed F. Marongiu, C. Cauli, S. Mariotti, Thyroid, hemostasis and thrombosis. J. Endocrinol. Invest. 27, 1065–1071 (2004)PubMed

go back to reference M. Homoncik, A. Gessl, A. Ferlitsch, B. Jilma, H. Vierhapper, Altered platelet plug formation in hyperthyroidism and hypothyroidism. J. Clin. Endocrinol. Metab. 92, 3006–3033 (2007)CrossRefPubMed M. Homoncik, A. Gessl, A. Ferlitsch, B. Jilma, H. Vierhapper, Altered platelet plug formation in hyperthyroidism and hypothyroidism. J. Clin. Endocrinol. Metab. 92, 3006–3033 (2007)CrossRefPubMed

go back to reference N. Jayaprasad, J. Francis, Atrial fibrillation and hyperthyroidism. Indian Pacing Electrophysiol. J. 5, 305–311 (2005) N. Jayaprasad, J. Francis, Atrial fibrillation and hyperthyroidism. Indian Pacing Electrophysiol. J. 5, 305–311 (2005)

go back to reference S. Bar-Sela, M. Ehrenfeld, M. Eliakim, Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch. Intern. Med. 141, 1191–1192 (1981)CrossRefPubMed S. Bar-Sela, M. Ehrenfeld, M. Eliakim, Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch. Intern. Med. 141, 1191–1192 (1981)CrossRefPubMed

go back to reference European Heart Rhythm Association, Heart Rhythm Society, V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, S.A. Hunt, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Zamorano, American College of Cardiology, American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 48, 854–906 (2006) European Heart Rhythm Association, Heart Rhythm Society, V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann, S.C. Smith Jr., A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, S.A. Hunt, R. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, S.G. Priori, J.J. Blanc, A. Budaj, A.J. Camm, V. Dean, J.W. Deckers, C. Despres, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J.L. Zamorano, American College of Cardiology, American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 48, 854–906 (2006)

go back to reference E. Marqusee, S.J. Mandel, The blood in hypothyroidism, in Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text, 8th edn., ed. by L.E. Braverman, R.D. Utiger (Lippincott Williams & Wilkins, Philadelphia, 2000), pp. 800–803 E. Marqusee, S.J. Mandel, The blood in hypothyroidism, in Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text, 8th edn., ed. by L.E. Braverman, R.D. Utiger (Lippincott Williams & Wilkins, Philadelphia, 2000), pp. 800–803

go back to reference D.J. Meiklejohn, H.G. Watson, Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 7, 523–525 (2001)CrossRefPubMed D.J. Meiklejohn, H.G. Watson, Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 7, 523–525 (2001)CrossRefPubMed

go back to reference J.V. Simone, C.F. Abildgaard, I. Schulman, Blood coagulation in thyroid dysfunction. N. Engl. J. Med. 273, 1057–1061 (1965)CrossRefPubMed J.V. Simone, C.F. Abildgaard, I. Schulman, Blood coagulation in thyroid dysfunction. N. Engl. J. Med. 273, 1057–1061 (1965)CrossRefPubMed

go back to reference B.O. Egeberg, Influence of thyroid function on the blood clotting system. Scand. J. Clin. Lab. Invest. 15, 1–7 (1963)CrossRef B.O. Egeberg, Influence of thyroid function on the blood clotting system. Scand. J. Clin. Lab. Invest. 15, 1–7 (1963)CrossRef

go back to reference A. Nordoy, H. Vik-Mo, H. Berntsen, Haemostatic and lipid abnormalities in hypothyroidism. Scand. J. Haematol. 16, 154–160 (1976)CrossRefPubMed A. Nordoy, H. Vik-Mo, H. Berntsen, Haemostatic and lipid abnormalities in hypothyroidism. Scand. J. Haematol. 16, 154–160 (1976)CrossRefPubMed

go back to reference R. Chadarevian, E. Bruckert, A. Ankri, I. Beucler, P. Giral, G. Turpin, Relationship between thyroid hormones and plasma D-dimer levels. Thromb. Haemost. 79, 99–103 (1998)PubMed R. Chadarevian, E. Bruckert, A. Ankri, I. Beucler, P. Giral, G. Turpin, Relationship between thyroid hormones and plasma D-dimer levels. Thromb. Haemost. 79, 99–103 (1998)PubMed

go back to reference S.G. Thompson, J. Kienast, S.D. Pyke, F. Haverkate, J.C. van de Loo, Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N. Engl. J. Med. 332, 635–641 (1995)CrossRefPubMed S.G. Thompson, J. Kienast, S.D. Pyke, F. Haverkate, J.C. van de Loo, Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N. Engl. J. Med. 332, 635–641 (1995)CrossRefPubMed

go back to reference R. Chadarevian, E. Bruckert, L. Leenhardt, P. Giral, A. Ankri, G. Turpin, Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. Clin. Endocrinol. Metab. 86, 732–737 (2001)CrossRef R. Chadarevian, E. Bruckert, L. Leenhardt, P. Giral, A. Ankri, G. Turpin, Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. Clin. Endocrinol. Metab. 86, 732–737 (2001)CrossRef

go back to reference S. Gullu, H. Sav, N. Kamel, Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur. J. Endocrinol. 152, 355–361 (2005)CrossRefPubMed S. Gullu, H. Sav, N. Kamel, Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur. J. Endocrinol. 152, 355–361 (2005)CrossRefPubMed

go back to reference B. Akinci, A. Comlekci, M. Ali Ozcan, T. Demir, S. Yener, F. Demirkan, F. Yuksel, S. Yesil, Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement. Endocr. J. 54, 45–52 (2007)CrossRefPubMed B. Akinci, A. Comlekci, M. Ali Ozcan, T. Demir, S. Yener, F. Demirkan, F. Yuksel, S. Yesil, Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement. Endocr. J. 54, 45–52 (2007)CrossRefPubMed

go back to reference C. Erem, O. Ucuncu, M. Yilmaz, M. Kocak, I. Nuhoglu, H.O. Ersoz, Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine 35, 75–80 (2009)CrossRefPubMed C. Erem, O. Ucuncu, M. Yilmaz, M. Kocak, I. Nuhoglu, H.O. Ersoz, Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine 35, 75–80 (2009)CrossRefPubMed

go back to reference M.P. Vanderpump, W.M. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clark, J. Grimley Evans, D.M. Hasan, H. Rodgers, F. Tunbridge, E.T. Young, The incidence of thyroid disorders in the community: a twenty-year follow-up of the Wickham survey. Clin. Endocrinol. 43, 55–68 (1995)CrossRef M.P. Vanderpump, W.M. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clark, J. Grimley Evans, D.M. Hasan, H. Rodgers, F. Tunbridge, E.T. Young, The incidence of thyroid disorders in the community: a twenty-year follow-up of the Wickham survey. Clin. Endocrinol. 43, 55–68 (1995)CrossRef

go back to reference C. Erem, Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin. Endocrinol. 64, 323–329 (2006)CrossRef C. Erem, Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin. Endocrinol. 64, 323–329 (2006)CrossRef

go back to reference B. Muller, D.A. Tsakiris, C.B. Roth, M. Guglielmetti, J.J. Staub, G.A. Marbet, Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur. J. Clin. Invest. 31, 131–137 (2001)CrossRefPubMed B. Muller, D.A. Tsakiris, C.B. Roth, M. Guglielmetti, J.J. Staub, G.A. Marbet, Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur. J. Clin. Invest. 31, 131–137 (2001)CrossRefPubMed

go back to reference Z. Cantürk, B. Cetinarslan, I. Tarkun, N.Z. Cantürk, M. Ozden, C. Duman, Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 13, 971–977 (2003)CrossRefPubMed Z. Cantürk, B. Cetinarslan, I. Tarkun, N.Z. Cantürk, M. Ozden, C. Duman, Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 13, 971–977 (2003)CrossRefPubMed

go back to reference S. Guldiken, M. Demir, B. Turgut, B.U. Altun, E. Arikan, M. Kara, Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr. J. 52, 363–367 (2005)CrossRefPubMed S. Guldiken, M. Demir, B. Turgut, B.U. Altun, E. Arikan, M. Kara, Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr. J. 52, 363–367 (2005)CrossRefPubMed

go back to reference P.C. Kek, S.C. Ho, D.H. Khoo, Subclinical thyroid disease. Singapore Med. J. 44, 595–600 (2003)PubMed P.C. Kek, S.C. Ho, D.H. Khoo, Subclinical thyroid disease. Singapore Med. J. 44, 595–600 (2003)PubMed

go back to reference C.H. Shih, S.L. Chen, C.C. Yen, Y.H. Huang, C.D. Chen, Y.S. Lee, K.H. Lin, Thyroid hormone receptor dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145, 2804–2814 (2004)CrossRefPubMed C.H. Shih, S.L. Chen, C.C. Yen, Y.H. Huang, C.D. Chen, Y.S. Lee, K.H. Lin, Thyroid hormone receptor dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145, 2804–2814 (2004)CrossRefPubMed